Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H25NO2 |
InChIKeySSIYPAHHMJMQFK-UHFFFAOYSA-N |
CAS Registry892569-53-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Jan 2017 | |
Neoplasms | Preclinical | CN | 01 Jan 2017 |